Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5938
-2.5 %
$ 152 M
Market Cap
-3.49
P/E
ADAP - SHARES OUTSTANDING
Shares Outstanding ADAP - Adaptimmune Therapeutics plc
1.21 B
LAST VALUE
13.60%
2 YEAR CAGR
15.60%
5 YEAR CAGR
28.13%
10 YEAR CAGR